Providing point-of-care solutions & OTC products that meet the needs of an evolving integrated healthcare system

BHR Biosynex is a market leader in point-of-care screening, diagnostics and therapies; delivering cutting-edge solutions to the NHS, private healthcare services and home users across the UK since 1990.

Our Commitment to the Armed Forces Community

We value and support Service personnel, veterans, reservists, military families, Cadet Force volunteers, and Armed Forces Cadet organisations.

Type 2 Diabetes has a significant and growing impact on patients, the NHS, and the economy

We're proud to have worked with the Company Chemists' Association to analyse the benefits of a Type 2 Diabetes screening service delivered by community pharmacies.

Download the report

Donald MacDonald

I would like to see all patients in my position and those with prediabetes have access to a nationwide screening programme. This would allow patients to be seen and treated quickly and regain control of their lives, just as I did through the MoREM® programme.

I have been living with the condition for 12 years, however over the last year my control deteriorated. MoREM® allowed me to understand what my HbA1c was, and then gave me the toolkit to make changes to my diet and lifestyle through the GRO Health app. My HbA1c is below the prediabetes range for the first time since I was diagnosed.

Ramesh Patel

Currently one in four hospital beds are occupied by people with diabetes complications and offering targeted support could reduce the number of people who develop diabetes in the first place.

Early diagnosis and action are key to tackling diabetes. Point-of-care testing, together with behavioural support helps to provide patients with a clear picture of their health.

Dr. Manisha Kumar

Over a quarter of people living in Greater Manchester will develop diabetes in their lifetime. Type 2 diabetes has a significant impact on the health outcomes of sufferer severy where as well as a preventable cost to the NHS and wider economy. That's why Greater Manchester launch edits 'Tackling Diabetes Together' strategy.

New models of care supporting early identification of people with Diabetes including utilising the skills of Community Pharmacy is part of our neighbourhood delivery model and are keen to support how we could develop more opportunities to deliver these services in Community Pharmacy settings.

Diabetes Screening
Donald Macdonald
Ramesh Patel
Dr. Manisha Kumar

Each year, an NHS-commissioned type 2 diabetes screening service by community pharmacies could:

SCREEN

1.5 million adults across England

IDENTIFY

45,000 undiagnosed diabetics & 180,000 pre-diabetics

PREVENT

over 18,000 people from developing diabetes
Testimonials

What Our Clients Say

Real Stories, Real Results: Discover How We’ve Made a Difference for Our Clients
5.00
Faiza Rafique, MPharm PG Dip
Clinical Director, Shine Clinical
5.00
Sandrine Rivoal Pluviaux, 2024
L&Q
5.00
Samantha Scott – Health Checks Project Manager
Kent Community Health NHS Trust
5.00
Mihir Patel – Pharmacist Manager
Mattock Lane Pharmacy
5.00
Amanda Chappell – Health Checks Project Manager
Bristol City Council
5.00
Rachel Linnett – Health Care Assistant
Andaman Surgery, Lowestoft
5.00
Chris Simmonds – Managing Director
Hallcross Medical Services Ltd
5.00
Thomas Fowler – Health Improvement Commissioning Manager
Public Health and Protection, Suffolk County Council

Our Accreditations